A new publication by the VSR’s scientific team is reported in the Journal of Medicinal Chemistry. The research work presents interesting findings on a newly-developed drug candidate for patients with Uveal Melanoma.

A new publication by the VSR’s scientific team is reported in the Journal of Medicinal Chemistry. The research work presents interesting findings on a newly-developed drug candidate for patients with Uveal Melanoma.

Vera Salus Ricerca Srl (VSR), in collaboration with the Departments of Drug & Health Sciences and Biomedical & Biotechnological Sciences...

Read More
The Board of Directors of Vera Salus Ricerca has voted in favour of the incorporation of FlavOncology in Switzerland with a dedicated, strong executive team comprising a mix of local entrepreneurs and key figures from the company’s shareholders.

The Board of Directors of Vera Salus Ricerca has voted in favour of the incorporation of FlavOncology in Switzerland with a dedicated, strong executive team comprising a mix of local entrepreneurs and key figures from the company’s shareholders.

The management of Vera Salus Ricerca Srl (VSR) has decided unanimously to continue FlavOncology’s development in Switzerland, recognizing the fertile...

Read More
Vera Salus Ricerca has successfully completed a 1-year training at BioArk (Switzerland) aimed at polishing the business developmental plans of FlavOncology, its proprietary drug platform for the cure of cancer patients.

Vera Salus Ricerca has successfully completed a 1-year training at BioArk (Switzerland) aimed at polishing the business developmental plans of FlavOncology, its proprietary drug platform for the cure of cancer patients.

During 2020, Vera Salus Ricerca Srl (VSR) has performed a Pre-incubation Program at BioArk (Valais, Switzerland) sponsored by the Ark...

Read More
Vera Salus Ricerca Srl, in collaboration with the Sicilian Zooprophylactic Institute and the National Reference Center for Toxoplasmosis, just published a research study in the Journal of Food Protection concerning the safety of novel foods with respect to Toxoplasma gondii infections. The paper, entitled “Edible insects and Toxoplasma gondii: is it something we need to be concerned about?”, provides evidences of the risk for public health poised by Toxoplasma gondii entering the human food chain through contaminated novel edible foods and causing toxoplasmosis disease in exposed individuals

Vera Salus Ricerca Srl, in collaboration with the Sicilian Zooprophylactic Institute and the National Reference Center for Toxoplasmosis, just published a research study in the Journal of Food Protection concerning the safety of novel foods with respect to Toxoplasma gondii infections. The paper, entitled “Edible insects and Toxoplasma gondii: is it something we need to be concerned about?”, provides evidences of the risk for public health poised by Toxoplasma gondii entering the human food chain through contaminated novel edible foods and causing toxoplasmosis disease in exposed individuals

Pubblicato uno studio sulla sicurezza alimentare da zoonosi di Toxoplasma Gondii, frutto della collaborazione scientifica tra VSR, IZSS e Ce.Tox...

Read More
The 3-years PhD-ITalent project has just come to an end. The project and its scientific program was a success. Consequently, the selected candidate has been promoted as a full-time Biomedical Researcher in the VSR Core Laboratory

The 3-years PhD-ITalent project has just come to an end. The project and its scientific program was a success. Consequently, the selected candidate has been promoted as a full-time Biomedical Researcher in the VSR Core Laboratory

Concluso con successo il progetto triennale PhD-ITalent sponsorizzato dal CRUI con l’assunzione a tempo indeterminato del candidato selezionato in qualità...

Read More
VSR was awarded a voucher from INNovaSouth for the implementation of new organisational models and innovative solutions to support the valorization of human resources in the workplace. The iNNovaSouth project is co‐funded by the Horizon 2020 Research and Innovation Program.

VSR was awarded a voucher from INNovaSouth for the implementation of new organisational models and innovative solutions to support the valorization of human resources in the workplace. The iNNovaSouth project is co‐funded by the Horizon 2020 Research and Innovation Program.

Vincitrice del bando INNovaSouth 2020 per l’implementazione di soluzioni innovative sul posto di lavoro

Read More
A co-development deal has been signed in 2019 with Bionexa Srl for the characterization of novel senolytic drugs from VSR’s Flav-x platform. The project, called FlavoLife, aims to develop innovative drugs to treat diseases associated with aging.

A co-development deal has been signed in 2019 with Bionexa Srl for the characterization of novel senolytic drugs from VSR’s Flav-x platform. The project, called FlavoLife, aims to develop innovative drugs to treat diseases associated with aging.

Siglato accordo commerciale con Bionexa Srl per ottenere nuovi senolitici dalla piattaforma farmaceutica Flav-x. Il progetto, chiamato FlavoLife, svilupperà farmaci...

Read More